A crucial element of regenerative healthcare and drug research lies in the ability to multiply human stem cell collections to sufficient quantities for therapeutic uses. Traditionally, restricted cell presence posed a significant obstacle to advancement in these fields. Consequently, considerable work has been directed towards optimizing protocols